Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder
This study has been terminated.
(Pfizer has terminated the execution of this protocol)
Sponsor:
Cedars-Sinai Medical Center
Collaborator:
Pfizer
Information provided by:
Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT00836069
First received: February 3, 2009
Last updated: May 29, 2009
Last verified: May 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | April 2010 |
| Estimated Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |